Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase
{{output}}
Introduction: Childhood chronic myeloid leukemia (CML) accounts for less than 3% of all childhood leukemias, hence, data on imatinib (IM) in adult CML patients has been largely extrapolated to children. We have analyzed our data ... ...
